RIGL

Rigel Pharmaceuticals Inc

A South San Francisco biotechnology company that develops and sells prescription medicines for blood disorders and cancer. Its FDA-approved drugs include Tavalisse for immune thrombocytopenia (a low blood-platelet condition) and Rezlidhia for a form of acute myeloid leukemia. Founded in 1996, the company shares its name with Rigel, a brilliant blue star in the Orion constellation whose Arabic name means "the foot of the giant."

CUSIP: 766559603HealthcareUS1 holder

Ownership Activity Financials Filings

RIGL

RIGL

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Completion of Acquisition or Disposition of Assets

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Termination of a Material Definitive Agreement

Results of Operations and Financial Condition